Skip to main content
1-featuredimage

Welcome to hubXchange's Antibody Therapeutics Xchange Boston 2026.

This event brings together senior-level scientists and executives from the pharmaceutical and biotech sectors to tackle key challenges in Target Selection & Mechanisms of Action, Lead Identification & Optimization, Formats & ScaffoldsBi/MultispecificsADC Linker Design & Conjugation Technologies, and ADC Cytotoxic Payload

Attendees can engage in roundtable discussions, pre-booked 1:1 meetingspresentations, and networking sessions with top industry experts, to foster collaboration and find innovative solutions to accelerate antibody therapeutics.

Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration and networking.

Boston | Tuesday 28th April 2026 | 08:00am - 06:10pm

 VIEW AGENDA    REGISTER FOR FREE    OUR PARTNERS    EVENT INFORMATION

Why choose hubXchange?

 

FULL AGENDA

Click the topic titles to find out more!

Loading
08:00
  1. Registration
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization
08:30
  1. Opening Address & Keynote Presentation: The Truth About Antibodies and Polyspecificity [Topic TBC]
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization
09:05
  1. Target Selection & Mechanisms of Action
    60 mins
    • Target Selection & Mechanisms of Action
    How can we address the challenge of candidate antigens being expressed in both diseased and healthy tissues to enhance selective targeting and minimize on-target toxicity? What strategies can improve ...
  2. Lead Identification & Optimization
    60 mins
    • Lead Identification & Optimization
  3. Formats & Scaffolds
    60 mins
    • Formats & Scaffolds
  4. Bi/Multispecifics
    60 mins
    • Bi/Multispecifics
  5. ADC Linker Design & Conjugation Technologies
    60 mins
    • ADC Linker Design & Conjugation Technologies
  6. ADC Cytotoxic Payload
    60 mins
    • ADC Cytotoxic Payload
    What cellular pathways are responsible for the altered intracellular trafficking or limited lysosomal release of ADC payloads, and how do these contribute to acquired resistance in tumor cells? How do ...
10:10
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization
10:45
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization
11:15
  1. Morning Refreshments
    10 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization
11:25
  1. Target Selection & Mechanisms of Action
    60 mins
    • Target Selection & Mechanisms of Action
  2. Lead Identification & Optimization
    60 mins
    • Lead Identification & Optimization
  3. Formats & Scaffolds
    60 mins
    • Formats & Scaffolds
  4. Bi/Multispecifics
    60 mins
    • Bi/Multispecifics
  5. ADC Linker Design & Conjugation Technologies
    60 mins
    • ADC Linker Design & Conjugation Technologies
  6. ADC Cytotoxic Payload
    60 mins
    • ADC Cytotoxic Payload
12:25
  1. Networking Lunch
    60 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization
13:25
  1. Spotlight Presentation: Engineering Unique Properties in Next-Gen Antibody Therapies [Topic TBC]
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization
14:00
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization
14:30
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization
15:00
  1. Afternoon Refreshments
    10 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization
15:10
  1. Spotlight Presentation: by CDD
    30 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization
15:45
  1. Target Selection & Mechanisms of Action
    20 mins
    • Target Selection & Mechanisms of Action
  2. Lead Identification & Optimization
    20 mins
    • Lead Identification & Optimization

    Bio-Rad

  3. Formats & Scaffolds
    20 mins
    • Formats & Scaffolds
  4. Bi/Multispecifics
    20 mins
    • Bi/Multispecifics
  5. ADC Linker Design & Conjugation Technologies
    20 mins
    • ADC Linker Design & Conjugation Technologies
  6. ADC Cytotoxic Payload
    20 mins
    • ADC Cytotoxic Payload
16:10
  1. Target Selection & Mechanisms of Action
    60 mins
    • Target Selection & Mechanisms of Action
  2. Lead Identification & Optimization
    60 mins
    • Lead Identification & Optimization
  3. Formats & Scaffolds
    60 mins
    • Formats & Scaffolds
    What is the minimum of sdAb architecture we have to try? How to efficiently link the screening of binding and functionality? How to mitigate the potential risk of reduced colloidal stability, increase ...
  4. Bi/Multispecifics
    60 mins
    • Bi/Multispecifics
    Why is reliance on the endogenous immune recognition system (TCE + MHC + antigen) insufficient for effective immune responses in many tumor settings? What are the barriers preventing next-generation a ...
  5. ADC Linker Design & Conjugation Technologies
    60 mins
    • ADC Linker Design & Conjugation Technologies
  6. ADC Cytotoxic Payload
    60 mins
    • ADC Cytotoxic Payload
    How can we effectively identify the optimal payload–linker combinations to enhance the efficacy and safety of antibody-drug conjugates (ADCs)? What strategies can be employed to address and mitigate l ...
17:10
  1. Drinks-Canape Reception
    60 mins
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Target Selection & Mechanisms of Action
    • ADC Linker Design & Conjugation Technologies
    • ADC Cytotoxic Payload
    • Lead Identification & Optimization

EVENT INFORMATION

3-featuredimage

DATES

Boston
28 April 2026
Tuesday 28th April 2026

 

Hilton Woburn Hotel

VENUE

Hilton Munich Airport Hotel

2 Forbes Rd
Woburn
MA 01801
United States

MAP

EVENT PARTNERS

4-featuredimage

EVENT PARTNERS

OUR MEDIA PARTNERS

5-featuredimage

REGISTRATION FORM - Register for free!

6-featuredimage

Complimentary Registration is only available for Senior Scientists & above, in Pharma & Bio Tech, with an active drug pipeline.
 

For Service Providers, please click here.